FTH-10772-36173
4 vaccinations
11 coded responses
44 check-ins
11 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 985 / WA
- Registered
- 2021-01-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-01-22
Registered in v-safe
-
2021-01-22
Dose 1 — Moderna
- 2021-01-22
- 2021-01-23
-
2021-01-24
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2021-01-25
- 2021-01-26
- 2021-01-27
- 2021-01-28
- 2021-01-29
-
2021-02-05
Survey response — day 14, dose 1MedDRA: Fatigue — Feeling: Good · Be unable to do your normal daily activitiesFree text: Transient fatigue.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-12
-
2021-02-18
Dose 2 — Moderna
- 2021-02-18
-
2021-02-19
Survey response — days 1–6 daily, dose 2MedDRA: Feeling abnormal — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-20
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Swollen lymph nodes (axillary & supraclavicular)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-21
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: lymphadenopathy: axillary and supraclavicularMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-22
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessFree text: Axillary & supraclavicular lymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-23
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness · HeadacheFree text: supraclavicular & axillary adenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-02-25
-
2021-03-04
Survey response — day 14, dose 2MedDRA: Exercise tolerance decreased, Fatigue, Feeling abnormal — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Intermittent fatigue, brain fog, decreased exercise/activity tolerance since receiving vaccine. Not back to baseline yet.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-05-20
- 2021-08-19
-
2021-12-03
Dose 3 — Moderna
-
2021-12-04
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy, Nasal congestion — Feeling: Poor · Site: Pain, Redness · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: nasal congestion, axillary adenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-12-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, SwellingFree text: Axillary adenopathyMedDRA releases: 2024-11 · check-in free text available
-
2021-12-07
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Itching · NoneAdult check-in
- 2021-12-12
- 2021-12-26
- 2022-01-09
- 2022-01-14
- 2022-03-04
-
2022-09-27
Dose 4 — Moderna
-
2022-09-27
Survey response — day 0, dose 4MedDRA: Brain fog — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Brain fogMedDRA releases: 2024-11 · check-in free text available
-
2022-09-28
Survey response — days 1–6 daily, dose 4MedDRA: Orthostatic hypotension, Palpitations — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Orthostatic hypotension, pounding heartMedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-09-30
-
2022-10-01
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Itching · HeadacheAdult check-in
- 2022-10-02
- 2022-11-10
- 2022-12-27
- 2023-03-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-22 | Moderna | |
| 2 | 2021-02-18 | Moderna | |
| 3 | 2021-12-03 | Moderna | No |
| 4 | 2022-09-27 | Moderna | No |
Free text
Release 3 — day 14, dose 1
Symptoms: Transient fatigue.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Brain fog
Systemic reaction (other): Swollen lymph nodes (axillary & supraclavicular)
Systemic reaction (other): lymphadenopathy: axillary and supraclavicular
Systemic reaction (other): Axillary & supraclavicular lymphadenopathy
Systemic reaction (other): supraclavicular & axillary adenopathy
Release 5 — day 14, dose 2
Symptoms: Intermittent fatigue, brain fog, decreased exercise/activity tolerance since receiving vaccine. Not back to baseline yet.
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): nasal congestion, axillary adenopathy
Systemic reaction (other): Axillary adenopathy
Release 12 — day 0, dose 4
Systemic reaction (other): Brain fog
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Orthostatic hypotension, pounding heart
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exercise tolerance decreased | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Brain fog | · | · | ✓ |
| SRO | Feeling abnormal | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Nasal congestion | · | · | ✓ |
| SRO | Orthostatic hypotension | · | · | ✓ |
| SRO | Palpitations | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release